Total planned funding: $177,475,624
Allocations
Countries/Regions
Ukraine | $177,475,624 |
Organizational Types
Unknown | $56,767,902 |
NGO | $37,921,651 |
Private Contractor | $30,240,981 |
Own Agency | $22,783,749 |
Multi-lateral Agency | $11,425,607 |
University | $7,827,000 |
Implementing Agency | $5,597,040 |
Other USG Agency | $3,061,694 |
Host Country Government Agency | $1,850,000 |
Program Areas
Governance and Systems | $80,870,973 |
Treatment | $27,549,052 |
Prevention | $20,784,688 |
Testing | $18,059,564 |
Management and Operations | $17,099,478 |
Care | $12,699,169 |
Budget Codes
OHSS: Health Systems Strengthening | $47,807,543 |
HVSI: Strategic Information | $19,663,684 |
HVCT: Testing: HIV Testing and Counseling | $18,059,564 |
HVMS: Management and Operations | $17,099,478 |
HTXS: Treatment: Adult Treatment | $15,117,938 |
HLAB: Laboratory Infrastructure | $13,399,746 |
HTXD: Treatment: ARV Drugs | $12,431,114 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $9,557,044 |
HVOP: Sexual Prevention: Other Sexual Prevention | $8,331,736 |
HVTB: Care: TB/HIV | $7,726,355 |
HKID: Care: Orphans and Vulnerable Children | $2,574,509 |
HBHC: Care: Adult Care and Support | $2,398,305 |
HMBL: Biomedical Prevention: Blood Safety | $2,133,557 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $218,994 |
Top Partner Programs
Not Available:
$53,702,618
Countries/Regions
USG Aggregated Agencies:
$18,032,013
Countries/Regions
Chemonics International:
$16,719,470
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions